The pathology of both MFS and acromelic dysplasias is largely associated with dysregulation of TGF-β superfamily signaling (13), highlighting the importance of FBN function in the ECM for regulating extracellular growth factor signaling. The gene discussed is FBN1; the disease is acromelic dysplasia.